Page last updated: 2024-10-29

ketamine and Gargoylism, Hunter Syndrome

ketamine has been researched along with Gargoylism, Hunter Syndrome in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kawamura, A1
Tsuboi, K1
Oka, A1
Sakaguchi, H1
Suzuki, Y1

Other Studies

1 other study available for ketamine and Gargoylism, Hunter Syndrome

ArticleYear
Anesthesia management in a child with mucopolysaccharidosis and toxic epidermal necrolysis: A case report.
    Paediatric anaesthesia, 2024, Volume: 34, Issue:1

    Topics: Anesthesia; Child; Child, Preschool; Humans; Ketamine; Male; Mucopolysaccharidosis II; Propofol; Ste

2024